131 results on '"Motiño, Omar"'
Search Results
2. Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics
3. Isolation of Primary Mouse Hepatocytes and Non-Parenchymal Cells from a Liver with Precancerous Lesions
4. A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet
5. Targeted Analysis of Glycerophospholipids and Mono-, Di-, or Tri-Acylglycerides in Liver Cancer
6. A Mouse Model of Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma Induced by Western Diet and Carbon Tetrachloride
7. Orthotopic Model of Hepatocellular Carcinoma in Mice
8. Protein regulator of cytokinesis 1: a potential oncogenic driver
9. 3,4-dimethoxychalcone induces autophagy and reduces neointimal hyperplasia and aortic lesions in mouse models of atherosclerosis
10. Acyl-CoA binding protein for the experimental treatment of anorexia.
11. Correction: An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABA receptor
12. An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABAA receptor
13. Inhibition of acyl-CoA binding protein (ACBP) by means of a GABAARγ2-derived peptide.
14. Paradoxical implication of BAX/BAK in the persistence of tetraploid cells
15. Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
16. Acyl coenzyme A binding protein (ACBP): An aging‐ and disease‐relevant “autophagy checkpoint”
17. Full-Spectrum CARS Microscopy of Cells and Tissues with Ultrashort White-Light Continuum Pulses
18. Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence
19. High plasma concentrations of acyl‐coenzyme A binding protein ( ACBP ) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP
20. Cardio-, hepato- and pneumoprotective effects of autophagy checkpoint inhibition by targeting DBI/ACBP
21. ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis
22. Immunization of mice with the self-peptide ACBP coupled to keyhole limpet hemocyanin
23. Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis
24. High plasma concentrations of acyl‐coenzyme A binding protein (ACBP) predispose to cardiovascular disease: Evidence for a phylogenetically conserved proaging function of ACBP.
25. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance
26. Cardio-, hepato- and pneumoprotective effects of autophagy checkpoint inhibition by targeting DBI/ACBP.
27. An obesogenic feedforward loop involving PPARγ, acyl-CoA binding protein and GABAA receptor.
28. EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway
29. Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects
30. Cyclooxygenase-2 expression in hepatocytes protects against hepatic ischemia/reperfusion injury in mice
31. Protective Role of Hepatocyte Cyclooxygenase‐2 Expression Against Liver Ischemia–Reperfusion Injury in Mice
32. Cyclooxygenase-2 expression in hepatocytes protects against liver fibrosis in mice through the regulation of miRNA23a-5p
33. Papel de la ciclooxigenasa-2 en la enfermedad hepática grasa no alcohólica
34. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet
35. La expresión de la ciclooxigenasa-2 en hepatocitos atenúa la esteatohepatitis no alcohólica y la fibrosis hepática en ratones
36. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice
37. La regulación de miR-183 en hígado por la ciclooxigenasa 2 es dependiente de la helicasa de RNA DDX5. Papel en la señalización de la insulina
38. Hepatic cyclooxygenase-2 expression protects against diet-induced steatosis, obesity and insulin resistance
39. La expresión hepática de la ciclooxigenasa-2 (COX-2) protege de la esteatosis, adiposidad y resistencia a la insulina inducida por dieta rica en grasa
40. Alternative Splicing of Neuronal Differentiation Factor TRF2 Regulated by HNRNPH1/H2
41. Regulación de la expresión de la 15-hidroxiprostaglandina deshidrogenasa (15-PGDH) en el carcinoma hepatocelular
42. 5-hydroxyprostaglandin dehydrogenase expression is downregulated in hepatocellular carcinoma: role in tumor growth
43. Regulation of MicroRNA 183 by Cyclooxygenase 2 in Liver Is DEAD-Box Helicase p68 (DDX5) Dependent: Role in Insulin Signaling
44. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance
45. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma
46. Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells
47. Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells
48. Cyclooxygenase-2 Is a Target of MicroRNA-16 in Human Hepatoma Cells.
49. Papel de la ciclooxigenasa-2 en el daño por isquemia/reperfusión en el hígado
50. Isolation of Primary Mouse Hepatocytes and Non-Parenchymal Cells from a Liver with Precancerous Lesions.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.